[Cost Evaluation of First-Year Treatment for Locally Advanced or Metastatic Urothelial Carcinoma with Chemotherapy Plus Avelumab vs Chemotherapy Plus Best Supportive Care: A Cost of Care Model]. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 26, n. 1, 2025. DOI: 10.7175/fe.v26i1.1581. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1581. Acesso em: 28 nov. 2025.